2MM: AI Roundup: Food and Drug Administration reviews liver injury prediction tool, Joint Commission launches healthcare artificial intelligence certification, governance playbooks aim to standardize adoption, and pediatric hospitals bring generative tools to t - 2 Minute Medicine
The US Food and Drug Administration is reviewing a tool that uses AI to predict liver injury, which could help you better manage patient care if you're in the healthcare sector. This is part of a broader trend of AI adoption in healthcare, with new certifications and governance playbooks emerging to standardize its use.
What happened
The FDA is looking at an AI tool that can predict liver injury, which is a significant development for healthcare providers. The Joint Commission has also launched a certification program for healthcare AI, aiming to ensure that these tools are used safely and effectively. Additionally, pediatric hospitals are starting to use generative AI tools, which could lead to new treatments and therapies.
Why it matters
As a business owner in the healthcare sector, you need to stay on top of these developments to provide the best possible care for your patients. Standardized governance and certification programs can help you navigate the complexities of AI adoption and ensure that you're using these tools responsibly.
The takeaway
You should keep an eye on how AI is being used in your industry and consider how you can apply these tools to improve your services. Start by looking into the new certifications and governance playbooks to understand how you can safely and effectively adopt AI in your business.
Our plain-English take, written from public reporting for operational business owners. Always read the original for full context.
Nayre builds the AI systems behind stories like this.
Chatbots, workflow automation, finance intelligence, and internal knowledge systems. Built for operational teams, shipped in days.